Two Sigma Advisers’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,900
| Closed | -$11K | – | 2683 |
|
|
2022
Q2 | $11K | Sell |
10,900
-13,200
| -55% | -$13.3K | ﹤0.01% | 2586 |
|
|
2022
Q1 | $38K | Sell |
24,100
-18,100
| -43% | -$28.5K | ﹤0.01% | 2616 |
|
|
2021
Q4 | $59K | Buy |
42,200
+3,000
| +8% | +$4.19K | ﹤0.01% | 2462 |
|
|
2021
Q3 | $82K | Sell |
39,200
-51,800
| -57% | -$108K | ﹤0.01% | 2338 |
|
|
2021
Q2 | $252K | Sell |
91,000
-1,900
| -2% | -$5.26K | ﹤0.01% | 2197 |
|
|
2021
Q1 | $354K | Sell |
92,900
-32,400
| -26% | -$123K | ﹤0.01% | 2163 |
|
|
2020
Q4 | $298K | Buy |
125,300
+3,300
| +3% | +$7.85K | ﹤0.01% | 2049 |
|
|
2020
Q3 | $206K | Sell |
122,000
-24,100
| -16% | -$40.7K | ﹤0.01% | 2146 |
|
|
2020
Q2 | $275K | Sell |
146,100
-4,600
| -3% | -$8.66K | ﹤0.01% | 2155 |
|
|
2020
Q1 | $208K | Buy |
+150,700
| New | +$208K | ﹤0.01% | 2156 |
|